Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment-Reference-Cited by-同舟云学术

Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment

Published:2018-09-14 Issue:2 Volume:44 Page:549-558
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Rimola Jordi^ORCID,Davenport Matthew S.,Liu Peter S.,Brown Theodore,Marrero Jorge A.,McKenna Barbara J.,Hussain Hero K.

Funder

Fundación Alfonso Martín Escudero

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1007/s00261-018-1775-x.pdf

Reference42 articles.

1. Llovet JM, Di Bisceglie AM, Bruix J, et al. (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698–711

2. Lewandowski RJ, Mulcahy MF, Kulik LM, et al. (2010) Chemoembolization for hepatocellular carcinoma: analysis in a 172-patient cohort. Radiology 255:955–965

3. Llovet JM, Real MI, Montaña X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739

4. Lo C-M, Ngan H, Tso W-K, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 35:1164–1171

5. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 37:429–442

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic values of contrast-enhanced MRI and contrast-enhanced CT for evaluating the response of hepatocellular carcinoma after transarterial chemoembolisation: a meta-analysis;BMJ Open;2024-04

2. Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis;Abdominal Radiology;2024-01-10

3. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment;World Journal of Gastroenterology;2022-07-14

4. Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment;European Radiology;2022-07-12

5. LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data;Abdominal Radiology;2021-05-23